Format

Send to

Choose Destination
Eur Heart J. 2015 Aug 29. pii: ehv407. [Epub ahead of print]

Questions and answers on antithrombotic therapy: a companion document of the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation†.

Author information

1
ACTION study Group, Institut de Cardiologie, INSERM_UMRS 1166, Pitié-Salpêtrière Hospital (AP-HP), UPMC Paris 6, France.
2
Division of Cardiology, University Hospital, Geneva, Switzerland Marco.Roffi@hcuge.ch.
3
Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital, Basel, Switzerland.
4
Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.
5
Istituto di Farmacologia, Università Cattolica del Sacro Cuore, Rome, Italy.
6
The content of this article does not necessarily reflect the opinion of the entire Task Force for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation nor of the Committee for Practice Guidelines of the European Society of Cardiology (ESC).The disclosure forms of all experts involved in the development of these guidelines are available on the ESC website http://www.escardio.org/guidelines ACTION study Group, Institut de Cardiologie, INSERM_UMRS 1166, Pitié-Salpêtrière Hospital (AP-HP), UPMC Paris 6, France Division of Cardiology, University Hospital, Geneva, Switzerland Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital, Basel, Switzerland Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands Istituto di Farmacologia, Università Cattolica del Sacro Cuore, Rome, Italy.

KEYWORDS:

Acute cardiac care; Acute coronary syndrome; Angioplasty; Anticoagulation; Antiplatelet; Apixaban; Aspirin; Atherothrombosis; Bivalirudin; Bypass surgery; Chest pain unit; Clopidogrel; Dabigatran; Diabetes; Early invasive strategy; European Society of Cardiology; Glycoprotein IIb/IIIa inhibitors; Guidelines; Heparin; High-sensitivity troponin; Myocardial ischaemia; Non-ST-elevation myocardial infarction; Platelet inhibition; Prasugrel; Recommendations; Revascularization; Rhythm monitoring; Rivaroxaban; Stent; Ticagrelor; Unstable angina

PMID:
26320115
DOI:
10.1093/eurheartj/ehv407

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center